Literature DB >> 30343733

An Update on Therapies for Proliferative Lupus Nephritis: How Certain Can We Be About the Evidence?

Andrew S Bomback1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30343733     DOI: 10.1053/j.ajkd.2018.07.007

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  3 in total

Review 1.  The Evolving Role of Calcineurin Inhibitors in Treating Lupus Nephritis.

Authors:  Yonatan Peleg; Andrew S Bomback; Jai Radhakrishnan
Journal:  Clin J Am Soc Nephrol       Date:  2020-03-09       Impact factor: 8.237

2.  Association of Urine sCD163 With Proliferative Lupus Nephritis, Fibrinoid Necrosis, Cellular Crescents and Intrarenal M2 Macrophages.

Authors:  Ting Zhang; Hao Li; Kamala Vanarsa; Gabriel Gidley; Chi Chiu Mok; Michelle Petri; Ramesh Saxena; Chandra Mohan
Journal:  Front Immunol       Date:  2020-04-15       Impact factor: 7.561

3.  Elevated soluble CD163 predicts renal function deterioration in lupus nephritis: a cohort study in Eastern China.

Authors:  Guangxia Yang; Naifeng Guo; Jun Yin; Jianhua Wu
Journal:  J Int Med Res       Date:  2021-11       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.